(VIANEWS) - Nuveen Quality (JPS), Flaherty & Crumrine Total Return Fund (FLC), AbbVie (ABBV) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Nuveen Quality (JPS) | 7.41 | -1.33% | 7.34% | 2022-08-26 18:23:15 |
| 2 | Flaherty & Crumrine Total Return Fund (FLC) | 17.92 | -0.78% | 7.11% | 2022-08-25 23:48:18 |
| 3 | AbbVie (ABBV) | 140.39 | 1.21% | 3.93% | 2022-09-08 14:55:11 |
| 4 | Turkcell Iletisim Hizmetleri AS (TKC) | 2.91 | -2.02% | 2.81% | 2022-08-28 13:23:08 |
| 5 | Panhandle Oil and Gas (PHX) | 3.56 | -2.73% | 2.25% | 2022-08-27 21:07:09 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Nuveen Quality (JPS) - Dividend Yield: 7.34%
Nuveen Investments, Inc. launched the Nuveen Preferred Securities Income Fund, a closed-end fixed income mutual fund. Nuveen Fund Advisors LLC, Spectrum Asset Management, Inc. co-manage the fund. The fund invests in fixed income markets across the United States. It invests primarily in preferred and investment-grade preferred bonds, as well as convertible securities. Convertible preferred securities that have been rated by S&P or Moody's are also included. It used to be known as Nuveen QPreferred Income Fund 2. Nuveen Preferred Securities Income Fund, which was established June 24, 2002, is based in the United States.
Volume
Today's last reported volume for Nuveen Quality is 350430, 34.39% below its average volume of 534085.
Nuveen Quality's last close was $7.51, 25.42% under its 52-week high of $10.07.
Nuveen Quality's Revenue
Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 160.82M for the twelve trailing months.
Nuveen Quality's Stock Yearly Top and Bottom Value
Nuveen Quality's stock is valued at $7.41 at 20:15 EST, way below its 52-week high of $10.07 and higher than its 52-week low of $6.98.
Nuveen Quality's Moving Average
Nuveen Quality's value is under its 50-day moving average of $7.46 and way below its 200-day moving average of $8.31.More news about Nuveen Quality.
2. Flaherty & Crumrine Total Return Fund (FLC) - Dividend Yield: 7.11%
Flaherty & Crumrine Total Return Fund Inc., a closed-ended balance mutual fund managed by Flaherty & Crumrine Incorporated is the founder and manager of Flaherty & Crumrine Incorporated. This fund is invested in both the fixed and public markets for US equity. The fund invests in stock of banks and utilities companies. It invests primarily in high-quality securities, including preferred securities as well as income-producing debt securities. The fund benchmarks its portfolio performance against the Barclays Capital U.S. The Aggregate Index, and the S&P 500 Index. The original name of the fund was Flaherty & Crumrine/Claymore Total Return Fund, Inc. Flaherty & Crumrine Total Return Fund Inc. formed August 26, 2003. It is based in the United States.
Volume
Today's last reported volume for Flaherty & Crumrine Total Return Fund is 41639, 135.6% above its average volume of 17674.
Flaherty & Crumrine Total Return Fund's last close was $17.92, 27.83% below its 52-week high of $24.83.
Flaherty & Crumrine Total Return Fund's Revenue
Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 19.41M for the twelve trailing months.
Flaherty & Crumrine Total Return Fund's Stock Yearly Top and Bottom Value
Flaherty & Crumrine Total Return Fund's stock is valued at $17.92 at 20:15 EST, way under its 52-week high of $24.83 and higher than its 52-week low of $17.25.
Flaherty & Crumrine Total Return Fund's Moving Average
Flaherty & Crumrine Total Return Fund's value is under its 50-day moving average of $18.27 and way under its 200-day moving average of $20.13.More news about Flaherty & Crumrine Total Return Fund.
3. AbbVie (ABBV) - Dividend Yield: 3.93%
AbbVie Inc. develops, produces, and markets pharmaceuticals worldwide. HUMIRA is an injectable therapy for autoimmune Behcet's disease; SKYRIZI for moderate to severe plaque psoriasis; RINVOQ to treat mild to moderately severe active rheumatoidarthritis in adults; IMBRUVICA for adults with chronic lymphocyticleukemia (CLL), or small lymphocytic lioma (SLL); and VENCLEXTA to treat chronic HCV genotype 1-6 patients. The company also offers CREON, an exocrine-pancreatic enzyme therapy to treat hypothyroidism. Linzess/Constella is used for irritable bowel syndrome and chronic idiopathic constipation. Lupron can be used for palliative care of advanced prostate cancer and endometriosis. Botox Therapeutic will treat patients with chronic HCV genotype 1-6 infection. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. collaborates with Dragonfly Therapeutics, Inc. It was founded in 2012, and its headquarters are in North Chicago (Illinois).
Volume
Today's last reported volume for AbbVie is 2752940, 50.59% below its average volume of 5571870.
AbbVie's last close was $140.52, 20.12% under its 52-week high of $175.91.
The company's growth estimates for the current quarter and the next is 9.2% and 29.7%, respectively.AbbVie's Revenue
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 57.35B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,AbbVie's stock is considered to be oversold (<=20).
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $140.39 at 20:15 EST, way below its 52-week high of $175.91 and way above its 52-week low of $105.56.
AbbVie's Moving Average
AbbVie's value is under its 50-day moving average of $145.38 and under its 200-day moving average of $144.24.More news about AbbVie.
4. Turkcell Iletisim Hizmetleri AS (TKC) - Dividend Yield: 2.81%
Turkcell Iletisim Hizmetleri A.S. offers digital services in Turkey and other countries such as Ukraine, Belarus, Northern Cyprus (Germany), and the Netherlands. The company operates via Turkcell Turkey and Turkcell International segments. The company offers mobile communication, fixed-business internet, business phone and loyalty programs, as well as work contact services. Digital business services include uninterrupted access, cybersecurity, data center internet of things, big and e-transformation technologies as well as managed services and cloud solutions. The company also offers various hardware and software solutions, as well as financing options. The company also offers digital services that include search, invoicing, and TL services, as well as information, entertainment and application services. The company also offers TV+ which allows subscribers to view series and other TV content whenever they like; fizy, an online music platform; magazine holders, a magazine and newspaper service; and yaani Browser, a mobile app. The company also offers BiP (an all-access communication application); goals pocket (a news and goal video application); and digital operator (a transaction and technology purchase application). It offers home internet and television services. It was founded in 1993 in Istanbul, Turkey.
Volume
Today's last reported volume for Turkcell Iletisim Hizmetleri AS is 209133, 66.73% below its average volume of 628593.
Turkcell Iletisim Hizmetleri AS's last close was $2.91, 41.8% under its 52-week high of $5.00.
Turkcell Iletisim Hizmetleri AS's Stock Yearly Top and Bottom Value
Turkcell Iletisim Hizmetleri AS's stock is valued at $2.91 at 20:15 EST, way under its 52-week high of $5.00 and way higher than its 52-week low of $2.33.
Turkcell Iletisim Hizmetleri AS's Moving Average
Turkcell Iletisim Hizmetleri AS's value is way above its 50-day moving average of $2.55 and way under its 200-day moving average of $3.31.More news about Turkcell Iletisim Hizmetleri AS.
5. Panhandle Oil and Gas (PHX) - Dividend Yield: 2.25%
PHX Minerals Incorporated acquires and develops natural gas properties and then manages them in the United States. It produces natural gas and crude oil as well as natural gas liquids. The company's main properties are in Oklahoma, Arkansas and Texas. The company had 252,443 net minerals in perpetual ownership; it leased 17,091 acres and owned working rights and royalty interests in 6,510 natural gas and oil wells. There were also 125 wells that are in process or being completed. The company sells products to many purchasers including pipeline companies and marketing firms. The former name of the company was Panhandle Oil and Gas Inc., but it changed its name in October 2020 to PHX Minerals Inc. PHX Minerals Inc. is a Oklahoma City-based company that was established in 1926.
Volume
Today's last reported volume for Panhandle Oil and Gas is 186447, 50.63% below its average volume of 377685.
Panhandle Oil and Gas's last close was $3.56, 28.51% under its 52-week high of $4.98.
Panhandle Oil and Gas's Sales
Panhandle Oil and Gas's sales growth is 314.4% for the present quarter and 45.2% for the next.
Panhandle Oil and Gas's Revenue
Year-on-year quarterly revenue growth grew by 78.4%, now sitting on 57.74M for the twelve trailing months.
Panhandle Oil and Gas's Stock Yearly Top and Bottom Value
Panhandle Oil and Gas's stock is valued at $3.56 at 20:15 EST, way under its 52-week high of $4.98 and way higher than its 52-week low of $2.07.
Panhandle Oil and Gas's Moving Average
Panhandle Oil and Gas's value is way above its 50-day moving average of $3.21 and way higher than its 200-day moving average of $2.96.More news about Panhandle Oil and Gas.